Načítá se...

Biomarkers and Surrogate Endpoints In Clinical Trials

One of the most important considerations in designing clinical trials is the choice of outcome measures. These outcome measures could be clinically meaningful endpoints that are direct measures of how patients feel, function and survive. Alternatively, indirect measures, such as biomarkers that incl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fleming, Thomas R., Powers, John H
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551627/
https://ncbi.nlm.nih.gov/pubmed/22711298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.5403
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!